Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
809
-
Total 13F shares, excl. options
-
213M
-
Shares change
-
-867K
-
Total reported value, excl. options
-
$70.5B
-
Value change
-
-$286M
-
Put/Call ratio
-
1.64
-
Number of buys
-
383
-
Number of sells
-
-320
-
Price
-
$330.81
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q3 2014
909 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q3 2014.
BIOGEN INC. - Common Stock (BIIB) has 809 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 213M shares
.
Largest 10 shareholders include FMR LLC (19M shares), PRIMECAP MANAGEMENT CO/CA/ (17.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.8M shares), VANGUARD GROUP INC (12.3M shares), State Street Corp (9.86M shares), Clearbridge Investments, LLC (7.89M shares), JPMORGAN CHASE & CO (6.92M shares), BlackRock Institutional Trust Company, N.A. (6.21M shares), JENNISON ASSOCIATES LLC (5.81M shares), and Capital Research Global Investors (5.46M shares).
This table shows the top 809 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.